NovoTTF-100L

DEVICE3 trials

Conditions

COVID-19NSCLCNon-small Cell Lung CancerPancreatic Adenocarcinoma

Phase 1

NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NovoCure Ltd.Non-small Cell Lung Cancer, NSCLC

Start: 2008-05-31End: 2011-07-31Target: 42Updated: 2011-09-27

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

NCT01971281

NovoCure Ltd.Pancreatic Adenocarcinoma

Start: 2013-11-30End: 2017-12-31Updated: 2017-09-13

Unknown Phase

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge

CompletedNCT04953234

NovoCure GmbHCOVID-19

Start: 2021-02-23End: 2021-04-26Updated: 2021-07-07

2025-04-23

PANOVA-4 (EF-39): Pilot study of tumor treating fields (TTFields) therapy with atezolizumab, gemcitabine (GEM), and nab-paclitaxel (NabP) as first-line (1L) treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC).

Journal of Clinical Oncology2024-01-202 citations

Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study

Frontiers in Microbiology2023-11-29

Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer.

Journal of Clinical Oncology2023-06-011 citations

Tumor treating fields (TTFields) concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer: The phase 3 PANOVA-3 study.

Journal of Clinical Oncology2023-01-24

Abstract A021: Tumor Treating Fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer: the phase 3 PANOVA-3 study

Cancer Research2022-11-15

Abstract CT234: PANOVA-3: A phase 3 study of tumor treating fields with gemcitabine and nab-paclitaxel for front-line treatment of locally advanced pancreatic adenocarcinoma

Cancer Research2022-06-15

PANOVA-3: A phase 3 study of tumor-treating fields with gemcitabine and nab-paclitaxel for frontline treatment of locally advanced pancreatic adenocarcinoma.

Journal of Clinical Oncology2022-06-011 citations

PANOVA-3: A phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic adenocarcinoma.

Journal of Clinical Oncology2022-01-191 citations

Abstract CT173: Tumor Treating Fields (150 kHz) concurrent with standard of care treatment for stage 4 non-small cell lung cancer (NSCLC) following platinum failure: The Phase III LUNAR study

Clinical Trials2019-07-012 citations

Abstract CT173: Tumor Treating Fields (150 kHz) concurrent with standard of care treatment for stage 4 non-small cell lung cancer (NSCLC) following platinum failure: The Phase III LUNAR study

Cancer Research2019-07-012 citations

Abstract CT176: Phase III PANOVA study of tumor treating fields (150 kHz) in combination with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC)

Cancer Research2019-07-01

Clinical Trials2019-07-01

Meta-analysis of toxicity data in thoracic and abdominal malignancies from: Clinical trials in tumor treating fields.

Journal of Clinical Oncology2019-05-20

Tumor treating fields concurrent with standard of care therapy for stage IV NSCLC following platinum failure: Phase III LUNAR study

Annals of Oncology2019-04-012 citations

Safety meta-analysis of clinical trials delivering TTFields to the upper torso

Annals of Oncology2019-04-01

Thermal safety and effectiveness of tumor treating fields’ delivery to the abdomen as determined by computational simulations.

Journal of Clinical Oncology2019-01-29

Abstract 3204: Transducer array configuration optimization for treatment of pancreatic cancer using Tumor Treating Fields (TTFields)

Cancer Research2018-07-013 citations

PANOVA-3: A phase 3 study of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma - Trial in progress

Annals of Oncology2018-06-01

PANOVA: A phase II study of TTFields (150 kHz) concomitant with standard chemotherapy for front-line therapy of advanced pancreatic adenocarcinoma—Updated efficacy results.

Journal of Clinical Oncology2017-05-207 citations

5 more papers not shown

NovoTTF-100L

Sponsors

Conditions

Phase 1

Unknown Phase

Related Papers